Since pro-inflammatory type I cytokines are generally viewed as having a larger role in the progression of ALS, type II (IL-4, IL-6, and IL-12) cytokines have been less studied in the experimental literature; consequently, there is less type II cytokine data. This evidence concerns the gene SGCG and amyotrophic lateral sclerosis.